Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperemic Efficacy of Intravenous Infusion of Adenosine in Heart Failure With Reduced Ejection Fraction

NCT03235700 is registered in ClinicalTrials.gov with Sejong General Hospital as lead sponsor.

NCT NCT03235700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03235700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperemic Efficacy of Intravenous Infusion of Adenosine in Heart Failure With Reduced Ejection Fraction
Lead sponsor
Sejong General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2017
Completion date
February 28, 2020
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, heart failure with reduced ejection fraction